News | December 13, 2022
US Federal Court dismisses cancer linkage associated with Zantac
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
In 2018 NATCO and Alvogen had filed an Abbreviated New Drug Application (ANDA) with PIV certification for the generic version of the product
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
Subscribe To Our Newsletter & Stay Updated
